Press Releases about Phasebio Pharmaceuticals Inc
PhaseBio Provides Pemziviptadil (PB1046) Program Update
December 21, 2021
Via Business Wire
PhaseBio Names Jonathan Birchall as Chief Commercial Officer
November 18, 2021
Via Business Wire
Via Business Wire
PhaseBio Announces Topline Results From Phase 2b Trial for Bentracimab
November 03, 2021
Via Business Wire
PhaseBio Appoints William D. Humphries to Board of Directors
September 15, 2021
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|